Ipsos Healthcare expands cardiovascular therapy monitor portfolio

Published on:

London, UK – Ipsos Healthcare, the global healthcare division of Ipsos, has added the Stroke Prevention in Atrial Fibrillation (SPAF) Monitor to its syndicated Cardiovascular Therapy Monitor Portfolio.

The SPAF Monitor, which arrives at a critical juncture in this therapy area, allows clients to understand and track SPAF treatment across the EU5, US, South Korea, Japan and Brazil. Q1 2013 data is now available and reveals current drug shares, doctors’ current and future prescribing intentions, and the attributes driving their decision-making. Ipsos Healthcare’s Cardiovascular Therapy Monitor Portfolio also covers Venous Thromboembolism (VTE), Pulmonary Arterial Hypertension (PAH) and Hypertension.

Dr Sabina Heinz, Head of Ipsos Healthcare’s Cardiovascular Therapy Monitor Portfolio, commented:

“For decades, Stroke Prevention in Atrial Fibrillation has been treated with Warfarin – which puts a considerable burden on the patient – or simply, with aspirin. Now, the SPAF treatment landscape has been transformed by the introduction of Novel Oral Anticoagulants (NOACs). Against this backdrop, our SPAF monitor will answer critical questions such as, ‘What split of drugs are doctors giving to their patients right now?’, and, more importantly, ‘What do they expect to be doing in 12 months’ time’?”

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."